Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)

SHA:600420 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	8,821	9,363	10,938	12,070	12,959	13,945
Revenue Growth	-15.36%	-14.39%	-9.38%	-6.86%	-7.07%	11.06%
Gross Profit Gross Profit Growth	2,582	2,925	4,116	4,532	4,868	6,036
Operating Income Operating Income Growth	874.53	1,114	1,553	983.4	841.24	1,078
Net Income Net Income Growth	718.59	941.6	1,084	691.88	627.79	568.28
Earnings Per Share EPS Growth	0.54	0.70	0.81	0.54	0.54	0.48
EPS Growth	-35.48%	-13.11%	48.72%	0.07%	12.52%	-12.29%

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
North-East China North-East China Growth	397.53	397.37	509.69
North-West China North-West China Growth	401.12	421.66	573.17
North China North China Growth	1,212	1,500	1,427
East China East China Growth	2,339	2,809	3,202
Central China Central China Growth	918.69	943.59	1,181
Southern China Southern China Growth	1,269	1,108	1,237
South-West China South-West China Growth	876.14	1,080	1,260
Overseas Overseas Growth	1,909	2,584	2,467
Total Total Growth	9,323	10,842	11,857

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	3,724	7,061	7,643	5,973	6,148	4,284
Total Debt Total Debt Growth	37.86	42.6	1,138	1,145	3,403	4,184
Net Cash (Debt) Net Cash Growth	3,686	7,018	6,505	4,828	2,745	99.84
Net Cash Growth	-26.27%	7.89%	34.74%	75.89%	2649.36%	-
Net Cash Per Share Net Cash Per Share Growth	2.75	5.23	4.85	3.79	2.37	0.08

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	1,030	1,698	2,256	1,720	2,856	1,680
Capital Expenditures CapEx Growth	-267.61	-263.83	-219.77	-357.19	-307.44	-521.44
Free Cash Flow Free Cash Flow Growth	762.35	1,434	2,036	1,363	2,548	1,158
Free Cash Flow Growth	-53.31%	-29.56%	49.37%	-46.50%	120.01%	-2.03%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	29.27%	31.25%	37.63%	37.55%	37.57%	43.28%
Operating Margin	9.92%	11.89%	14.19%	8.15%	6.49%	7.73%
Pretax Margin	12.07%	14.18%	15.30%	9.09%	7.59%	6.58%
Profit Margin	8.15%	10.06%	9.91%	5.73%	4.84%	4.08%
FCF Margin	8.64%	15.32%	18.62%	11.29%	19.66%	8.31%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.300	0.300	0.300	0.100	0.100	0.100
Dividend Per Share Growth	50.00%	0%	200.00%	0%	0%	0%
Dividend Yield	3.44%	3.04%	2.64%	1.09%	1.19%	1.05%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	16.29	14.39	14.78	18.98	14.89	18.74
Forward PE	-	11.16	11.94	10.42	10.42	10.42
P/FCF Ratio	15.36	9.44	7.86	9.63	3.67	9.20
PS Ratio	1.33	1.45	1.46	1.09	0.72	0.76

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 16, 2026

Data Sources Report a data error